This work presents potentially important findings suggesting that a combination of transcranial stimulation approaches applied for a short period could improve memory performance after administration.
BuzzFeed on MSN15d
People Are Sharing The Worst Ending To A Date They've Had, And Ooof, Some Of These Are Pretty BadNeedless to say, dating can be tough. For every one good date, you usually have like three bad ones. This can be especially ...
With the dogs having proven themselves to be faster and more accurate in detecting spills, IISD-ELA scientists say canines ...
A randomised trial finds that a targeted elimination diet based on IBS-specific IgG antibodies significantly improves ...
Low-calorie, high-fiber vegetables like Brussels sprouts and asparagus can help you lose weight. Discover the 13 best ...
In the second episode of The Deep End, listeners hear what it’s like to live with severe depression and the backstory of an experimental treatment.
Hosted on MSN17d
Imvax Secures $29 Million to Advance Glioblastoma Therapy TrialImvax’s experimental therapy for newly diagnosed glioblastoma (ndGBM). The Phase 2b trial, a randomized, multicenter, double-blind, placebo-controlled study, is assessing the safety and efficacy ...
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...
Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim ...
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback